CoChat

Venlafaxine for Treatment-Resistant Unipolar Depression

NIERENBERG, ANDREW A., FEIGHNER, JOHN P., RUDOLPH, RICHARD, COLE, JONATHAN O., SULLIVAN, JOANNE · 1994 · Journal of Clinical Psychopharmacology

The DOI matches its Crossref record.

Abstract

The purpose of this study is to evaluate the novel antidepressant venlafaxine for the management of treatment-resistant unipolar depression. We gave unblinded venlafaxine to 84 consecutive outpatients and inpatients who met DSM-III-R criteria for major depression and who had failed to respond to at least three adequate trials of antidepressants from at least two different antidepressant classes or electroconvulsive therapy, plus at least one attempt at augmentation. Patients were evaluated after a drug free period at baseline and regular intervals with the 21-item Hamilton Rating Scale for Depression (HAM-D-21), Montgomery-Asberg Depression Rating Scale (MADRS), and the Clinical Global Impressions Scale Improvement item (CGI). Full response for each scale was defined as follows: HAM-D-21 score of 8 or lower, a MADRS score of 12 or lower, and CGI score of 1; partial responses was defined as a 50% decrease in the HAM-D and MADRS, with final scores greater than 8 and 12, respectively, and for the CGI, a score equal to 2. About a third of patients were considered to be either full or partial responders (32.9% by HAM-D-21, 30.0% by MADRS, and 40% by CGI) after 12 weeks of venlafaxine treatment. To date, about 46% of responders have sustained their response for at least 3 months after the acute response. Venlafaxine is effective for a significant, but small, minority of patients with rigorously defined triple-resistant depression; the improvement was maintained for about half of the responders for the first 3 months of maintenance therapy.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004714-199412000-00008

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cited by

See all 200

Metadata

Authors
NIERENBERG, A. A., FEIGHNER, J. P., RUDOLPH, R., COLE, J. O., & SULLIVAN, J.
Affiliations
Harvard University (US)
Venue
Journal of Clinical Psychopharmacology
Published
1994-12
Volume
14
Issue
6
Pages
419???423
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2027044241
Cited by
198
References
0
Citations by year
2025: 3 · 2023: 1 · 2022: 5 · 2021: 6 · 2019: 3 · 2018: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 1
FWCI
8.95
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
Keywords
venlafaxine, treatment-resistant depression, major depressive disorder, antidepressant efficacy, maintenance therapy, augmentation therapy, electroconvulsive therapy
MeSH terms
Venlafaxine Hydrochloride, Adult, Aged, Cyclohexanols, Depressive Disorder, Female, Humans, Male, Middle Aged, Personality Assessment, Personality Inventory, Treatment Outcome, Antidepressive Agents, Second-Generation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Venlafaxine for Treatment-Resistant Unipolar Depression. https://app.cochat.ai/papers/10.1097/00004714-199412000-00008
The paper
NIERENBERG, A. A., FEIGHNER, J. P., RUDOLPH, R., COLE, J. O., & SULLIVAN, J. (1994). Venlafaxine for Treatment-Resistant Unipolar Depression. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199412000-00008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.